ProfileGDS5678 / 1451850_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 10% 10% 10% 7% 10% 13% 13% 10% 10% 9% 10% 10% 11% 10% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.27810
GSM967853U87-EV human glioblastoma xenograft - Control 22.2525410
GSM967854U87-EV human glioblastoma xenograft - Control 32.2499210
GSM967855U87-EV human glioblastoma xenograft - Control 42.113837
GSM967856U87-EV human glioblastoma xenograft - Control 52.1949110
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.3675713
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.360713
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.2276810
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.2165810
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.211199
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.2369410
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.2230610
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.2597711
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.2459410